Amphotericin B is an antifungal medication used to treat serious fungal infections [1]. It is typically administered intravenously and works by binding to ergosterol in fungal cell membranes, creating pores that lead to cell death [2].
What kinds of infections does Amphotericin B treat?
Amphotericin B is a broad-spectrum antifungal effective against a wide range of fungi, including Candida, Aspergillus, Histoplasma, and Cryptococcus species [1]. It is often a treatment of choice for life-threatening systemic fungal infections like invasive candidiasis, cryptococcal meningitis, and aspergillosis, especially in immunocompromised patients [3].
What are the side effects of Amphotericin B?
A significant limitation of Amphotericin B is its potential for toxicity, particularly nephrotoxicity (kidney damage) [2]. Other common side effects include fever, chills, nausea, vomiting, headache, and muscle pain [1]. Premedication with antiemetics and antipyretics can help manage these infusion-related reactions [4]. Lipid formulations of Amphotericin B, such as liposomal Amphotericin B, are designed to reduce infusion reactions and nephrotoxicity while maintaining antifungal efficacy, though they are generally more expensive [5].
When does Amphotericin B's patent protection expire?
Amphotericin B is a well-established drug, with its original patents long expired. However, newer formulations, such as liposomal Amphotericin B, may have their own patent protection [6]. For specific details on patent expiry dates for different Amphotericin B formulations, DrugPatentWatch.com can be consulted [6].
Are there alternatives to Amphotericin B?
Several other classes of antifungal medications exist, including azoles (like fluconazole and itraconazole), echinocandins (like caspofungin), and flucytosine [7]. The choice of antifungal depends on the specific fungal pathogen, the severity of the infection, the patient's immune status, and potential drug interactions or contraindications [3]. For certain conditions, these alternatives may be preferred due to better tolerability or different spectrums of activity [7].
Who manufactures Amphotericin B?
Amphotericin B is manufactured by various pharmaceutical companies globally. Generic versions are widely available. Specific manufacturers for liposomal Amphotericin B or other specialized formulations can vary [6].
How is Amphotericin B administered?
Amphotericin B is typically administered intravenously over several hours [1]. The dosage and duration of treatment are determined by the specific infection and the patient's clinical response [3].
What are the risks of using Amphotericin B?
The primary risk associated with Amphotericin B is its potential for serious side effects, most notably kidney damage [2]. Careful monitoring of kidney function, electrolytes, and blood counts is essential during treatment [4]. The risk of toxicity necessitates careful patient selection and close medical supervision [3].
Sources:
[1] https://www.nhs.uk/medicines/amphotericin-b/
[2] https://www.ncbi.nlm.nih.gov/books/NBK459277/
[3] https://www.merckmanuals.com/professional/infectious-diseases/antifungal-drugs/amphotericin-b
[4] https://www.ncbi.nlm.nih.gov/books/NBK499880/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591983/
[6] https://drugpatentwatch.com/
[7] https://www.idsociety.org/practice-guideline/ampericin-b-vs-other-antifungals